These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 240046)

  • 1. [Proceedings: Antihypertensive effects of LB-46 (beta blockader)].
    Takeuchi N; Takekoshi J; Murakami E
    Jpn Circ J; 1975 Jul; 39(7):885. PubMed ID: 240046
    [No Abstract]   [Full Text] [Related]  

  • 2. Position of beta blockers in antihypertensive therapy.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S1-87. PubMed ID: 2439810
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of LB 46 on the blood pressure in essential hypertension.
    Duner H
    Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antihypertensive effect of beta-blockaders].
    Liebau H; Jarosch von Schweder W
    Verh Dtsch Ges Inn Med; 1974; 80():268-72. PubMed ID: 4156114
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
    Heinze A; Wessels F; Losse H
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():380-2. PubMed ID: 7887
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 8. Pindolol.
    Med Lett Drugs Ther; 1983 Feb; 25(628):13-4. PubMed ID: 6130467
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 10. The hypotensive action of LB 46.
    Doyle AE; Morgan TO; Louis WJ; Dawborn JK; Anavekar SN
    Indian Heart J; 1972 Jun; 24():Suppl 1:231-5. PubMed ID: 4147278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of pindolol on experimental hypertension in the dog. Comparison with propranolol, practolol, oxprenolol, bupranolol, alprenolol and butoxamine].
    Montastruc P; Besombes JP; Tran MA
    Arch Farmacol Toxicol; 1977 Aug; 3(2):93-100. PubMed ID: 21636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the use of a beta-blocking agent in the community treatment of arterial hypertension].
    Bucci A; Catalucci AM; Giampaoli S
    Clin Ter; 1981 Jun; 97(5):521-7. PubMed ID: 6115733
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Beta-blocking drugs.
    Pacey SM
    Med J Aust; 1973 Sep; 2(10):521. PubMed ID: 4147999
    [No Abstract]   [Full Text] [Related]  

  • 14. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
    Abetel G
    Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bopindolol in the treatment of mild and moderate arterial hypertension].
    Monaci R; Morganti G; Cecchin A; Morandini M
    Minerva Cardioangiol; 1988 Oct; 36(10):495-7. PubMed ID: 2906412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effect of beta-adrenergic blockers in the treatment of hypertension with regard to a decrease in peripheral resistance].
    Trifunović S
    Lijec Vjesn; 1984; 106(11-12):526-30. PubMed ID: 6151619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
    Mattioli G; Ricci S; Teglio V
    Minerva Cardioangiol; 1980 May; 28(5):295-302. PubMed ID: 6111047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.